Reata Pharmaceuticals Inc

PNC FINANCIAL SERVICES GROUP, INC.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

4,156

Value ($000)

424

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	424	0.0%	4,156	6/30/2023
2023 Q1	5/15/2023	372	0.0%	4,096	3/31/2023
2022 Q4	2/10/2023	158	0.0%	4,165	12/31/2022
2022 Q3	11/10/2022	103	0.0%	4,096	9/30/2022
2022 Q2	8/12/2022	124	0.0%	4,102	6/30/2022
2022 Q1	5/12/2022	132	0.0%	4,042	3/31/2022
2021 Q4	2/11/2022	108	0.0%	4,105	12/31/2021
2021 Q3	11/5/2021	1,017	0.0%	10,112	9/30/2021
2021 Q2	8/6/2021	1,433	0.0%	10,126	6/30/2021
2021 Q1	5/7/2021	1,015	0.0%	10,194	3/31/2021
2020 Q4	2/12/2021	1,262	0.0%	10,204	12/31/2020
2020 Q3	11/6/2020	990	0.0%	10,171	9/30/2020
2020 Q2	8/28/2020	1,730	0.0%	11,088	6/30/2020
2020 Q1	5/8/2020	1,638	0.0%	11,346	3/31/2020
2019 Q4	2/7/2020	2,258	0.0%	11,046	12/31/2019